1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Malignant Neoplasms: new trials by email Literature Review of Malignant Neoplasms trials Research Report on Malignant Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma SLC-3010 + Axitinib, Axitinib - Clear Cell Renal Cell Carcinoma, Neoplasms | Phase 2 | Recruiting | Yonsei University | 78 | 2026-03-01 | 2026-03-13 |
| Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases Naderin, Standard Therapy - Malignant Neoplasms, Tuberculosis (TB) | Phase 2 / Phase 3 | Completed | MIPO Clinic | 75 | 2013-05-15 | 2026-06-30 |
Neoplasms (2) · Carcinoma, Renal Cell (1) · Hepatitis C (1) · Neutropenia (1) · Tuberculosis (1)
Actinomycetales Infections (1) · Adenocarcinoma (1) · Agranulocytosis (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Carcinoma (1) · Communicable Diseases (1) · Cytopenia (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Flaviviridae Infections (1) · Gram-Positive Bacterial Infections (1) · Hematologic Diseases (1)
Axitinib (1) · Standard of Care (1) · sodium nucleinate (1)
MIPO Clinic (1) · Yonsei University (1)
South Korea (1)